Table 3 Description of morbidity groups
Morbidity groupsa | ICD-10 codes | ATC codes | Codes added + or removed-b |
|---|---|---|---|
Unmodified diagnostic categories | Â | Â | Â |
Tuberculosis (03) | A15A19,B90,K230,K673,K930,M011,M490,M900,N330,N740, N741,O980,P370 | J04A | J01GA01- J01GB04- |
Human immunodeficiency virus disease (05) | B20-B24,F024,R75,Z21 | J05AE,J05AF,J05AG,J05AR, J05AX07-J05AX09 except J05AF08 | J05AF05+ |
Diabetes mellitus (22) | E10-E14,G590,G632,H360, M141,N083,O24 | A10 | Â |
Mental and behavioral disorders due to alcohol (25) | F10 | N07BB | N07BB+ |
Schizophrenia, schizotypal and delusional disorders (27) | F20-F29 | N05A , except N05AN | N05AD0+ N05AL0+ |
Mood [affective] disordersc (28) | F30-F39 | N06A,N06C,N05AN except N06AX01 and N06AX02 | Â |
Other mental and behavioral disordersd(29) | F04-F09,F40-F99 not F803 | N05B,N05C,N06B | N05BD0+ N05BX0+ N05C + N06B+ |
Alzheimer’s diseasee (30) | F00,G30 | N06D not N06DX02 |  |
Multiple sclerosis* (31) | G35 | L03AB02,L03AB07,L03AB08, L03AX13 | Â |
Epilepsy (32) | G40-G41,F803 | N03 | N03AA0+ |
Hypertensive disease (38) | I10-I15,O10-O11,O13-016 | C02,C03 except C03C,C04AB, C07,C08,C09 | C04AB + C07 + C08 + C09+ |
Conduction disorders and cardiac arrhythmias (43) | I44-I49 | C01A,C01B,C01CA02,C01EB10 | C01CA02+ |
Heart failuref (44) | I50 | C01CA04, C01CA07,C01CE,C01CX,C03C | C01CA04+ C01CX+ |
Crohn’s disease and ulcerative colitis (65) | K50-K51 | A07EA,A07EC | A07EA+ |
Infections of the skin and subcutaneous tissue* (77) | L01,L02,L08 | D06,P03 | Â |
Hyperplasia of prostate (94) | N40 | G04BD,G04C | G04BD + G04C+ |
Inflammatory diseases of female pelvic organs* (97) | N70-N77, except N740 and N741 | G01 | Â |
Poisoning by drugs and biological substances* (122) | T36-T65 | V03AB,H04AA01 | Â |
Subgroups of diagnostic categories | Â | Â | Â |
Paludism* (06-) | B50-B54 | P01B not P01BA02 | Â |
Parasitosis* (06-) | B55-B83, B89 | P01A,P01C,P02 | Â |
Hepatitis B or C (06-) | B16-B18 | L03AB01,L03AB04,L03AB05,L03AB06,L03AB09,L03AB10, L03AB11, J05AF08, J05AF10, J05AF11 | J05AB04- J05AF05- L03AB01+ L03AB06+ L03AB09+ L03AB11+ |
Viral diseases* (06-) | A60,A80-A99,B00-B15,B19, B25-B34,B941,B942,B97,J12, J171,J203-J207,J210 | J05AA, J05AB, J05AC03, J05AD, J05AX except J05AX07-J05AX09 | Â |
Anemia – nutritional* (20-) | D50-D53 | B03A, B03B |  |
Non nutritional anemia g (20-) | D55-64 | B03XA | Â |
Neutropenia* (21-) | D70 | L03AA | Â |
Thyroid disorders (23-) | E00-E07 | H03 | Â |
Other endocrine, nutritional and metabolic diseases* (23-) | remainder of E00-E90 | H01AB, H01AC, H01AX, H01C except H01CB01 | Â |
Obesity* (23-) | E66 | A08 | Â |
Hyperlipidemia (23-) | E780-E785 | C10 | Â |
Mental and behavioral disorders due to opioids* (26-) | F11,F19 | N07BC | Â |
Mental and behavioral disorders due to tobacco (26-) | F17 | N07BA | N07BA+ |
Migraine (34-) | G43 | N02C | N02C+ |
Parkinson’s disease (34-) | G20-G22 | N04,except N04BC08 | N04BC01+ N04BC06 + h N04BC07+ |
Conjunctivitis* (36-) | H10 | S01A, S01GX | Â |
Glaucoma (36-) | H40, H42 | S01E | Â |
Eye inflammation* (36-) | H00-H05,H11-H16,H20, H22 | S01B, S01C | Â |
Disorders of external ear* (37-) | H601-H609,H62 | S02, S03 | Â |
Vertigo* (37-) | H81,H82 | N07C | Â |
Influenza* (49-) | J09-J11 | J05AH, J05AC02 | Â |
Other acute upper respiratory infections* (49-) | J00-J06, not J020,J028,J030, J038 | R01, R02, R05 | Â |
Other diseases of upper respiratory tract – allergy (53-) | J30,L50 | R06, V01 | R06 + V01+ |
Hemorrhoids* (69-) | I84, O224, O872 | C05A | Â |
Functional disorders of the digestive system* (76-) | K58, K59 | A03, A06, A07DA, A07B, A07CA | Â |
Psoriasis (78-) | L40 | D05, L04AA21, L04AA15 | D05 + L04AA21+ L04AA15+ |
Dermatitis* (78-) | L20-L39, not L303 | D07, D11AX14, D11AX15 | Â |
Acne* (79-) | L70,L718,L719,L730 | D10 | Â |
Gout (83-) | M10 | M04A | Â |
Osteoporosis (89-) | M80-M82 | H05, M05BA, M05BB | H05 + M05BA + M05BB+ |
Transplanted organ status (129-) | K771,K932,L991,N165,T860, T861-T864,T8681,T8682,Z94 | L04AA02-10, L04AX01, L04AC01, L04AC02, L04AD01, L04AD02 | Â |
Multiple morbidities groups | Â | Â | Â |
Gastroenteritis of presumed infectious origin* (01–02) | A00-A09, not A064-A066, K521 | A07A, A07F |  |
Ischemic heart diseases (39–41) | I20-I25 | C01DA, C01DX12, C01DX16 | C01DX12+ |
Reactive airway diseasei (54, 55) | J40-J47 | R03 | R03AA + R03AB + R03BZ + R03CA + R03CB+ |
Diseases of esophagus and peptic ulcer (59–61) | K20-K31, not K230 and K231 | A02BA- A02BD, A02X02 |  |
Malignant neoplasm (07–15) | C00-C97 | A04AA, A04AD12, L01, L02, L03AC01, L03AX03, L03AX12 L04AX02, V03AF, V03AG, V03AH, V10A, V10B, V10XX01 | L03AA-m A04AD12+ L02+ L03AC01+,L03AX03+,L03AX12+ L04AX02 + V03AF + V03AG + V03AH + V10A + V10B + V10XX01+ |
Inflammatory polyarthritis and connective tissue disorders (83,85-)j | M05-M09, M30-M36, M45 | H02A, H02B,L04AA13,L04AB01, L04AB04, L04AX03, M01B, M01CA, M01CB, P01BA02 | L04AX03+ M01B + M01CA+ |
Pain (80-83-,85-88-,111,112-)k | M50-M51,M54,R07,R10, R30, R51, R52, remainder of M60-M79 | M01A, M03B, M03C, M09, N02A, N02B | M03B + M03C + M09+ N02B+ |
Mycosis (06-,50-)* | B35-B49, J172 | D01, J02 | Â |
Bacterial infection or septicemia* (04,06-,50-,51-,88-) | A064-A066, A20-A79 (except A30, A31, A60), B95,B96, B99, D733, E321, G00, G01, G042, G060-G062, G07, H600, J020, J028, J030, J038, remainder of J13-J20, J36, J390, J391, J851-J853, K046, K047, K1020, K1021, K113, K122, K351, K570, K572, K574, K578, K61,K630, K750, L00, L03-L05, M00, M010-M013, M03, M600, M630-M632, M650, M651; M680, M710, M711, M730, M731, N151, N160, N340, N412, N450, N459, N751, N764, O85, O911 | J01 | Â |
Thrombo-embolic risk or disease (34-, 42-,45-,46-,48,101-,102-,106-)l | G08, I260,I269,I2720, I63-I66,I676, I693, I694, I698, I70, I731,I74, I77, I80-I82, O032, O037, O042, O047, O052, O057, O062, O067, O072, O077, O082, O223, O225, O871, O873 | B01A | Â |
Hemorrhage risk or disease* (21-, 45-,46-) | D65-D68, D693-D699 | B02,L03AC02 | Â |